Cardisio

S‍ummery

Cardisio is an internationally active medtech company that has developed a highly precise, non-invasive method for early diagnosis of heart disease using AI-based cardiosiography. The technology is used in practices and clinics worldwide and achieves a diagnostic accuracy of around 90%. Cardisio has a growing network of international sales partners and supports doctors and medical institutions with scientifically validated data, practical application expertise and a reliably scalable diagnostic solution.

Industry

Healthcare

Contribution

Assisting Cardisio in developing and implementing an international growth strategy and strategically preparing for market entry in the USA. This includes positioning cardiosiography in the global medtech environment, expanding international sales partnerships and adapting the business model to regulatory and market-specific requirements. In addition, we support Cardisio in setting up scalable structures, optimizing communication and sales processes, and preparing clinical and commercial activities for the US market.

‍

Vision

Cardisio is working to create a world in which everyone worldwide has easy access to scientifically validated, AI-based heart diagnostics at any time, in order to identify avoidable heart diseases at an early stage, protect lives and sustainably relieve the burden on health systems.

‍